title: Overexpression of the thymosin beta-4 gene is associated with malignant progression of SW480 colon cancer cells.
abstract: Thymosin beta-4 (Tbeta-4), a small peptide originally isolated from calf thymus, modulates the formation of F-actin microfilaments by sequestering the monomeric G-actin. Recent studies have shown that overexpression of the Tbeta-4 gene occurs not only in many human carcinomas but also in the highly metastatic melanomas and fibrosarcomas. However, little is known about the specific growth advantages acquired by different tumors from this genetic abnormality. To address the above questions, Tbeta-4-overexpressing human colon carcinoma (SW480) cells were established by stable transfection and their phenotypic changes were monitored. We found that both the morphology and the cortical actin cytoskeleton of SW480 cells were altered by Tbeta-4 overexpression. Moreover, both cellular level and that distributed over the intercellular junctions of the E-cadherin were decreased in the Tbeta-4 overexpressers, which were accompanied by a twofold increase in their saturation densities. Meanwhile, these cells also exhibited an increased ability to form colonies in soft agar. Interestingly, a dramatic increase of growth rate was detected in the Tbeta-4 overexpressers, which might be attributed to an accelerated proliferation induced by c-Myc that was activated by nuclear beta-catenin. Finally, a motility increase of these cells was demonstrated by two independent migration assays, which was accompanied by an enhanced focal contact. Taken together, our data suggest that the drastic growth property and motility changes of the SW480 cells overexpressing Tbeta-4 gene are due mainly to a deregulated cell-cell adhesion arisen from the downregulation of E-cadherin, plus uncontrolled cell proliferation owing to the upregulation of beta-catenin, both resulted from a breakdown of actin microfilaments caused by the overexpression of this G-actin sequestering peptide.
authors.affiliation: Institute of Clinical Medicine, School of Medicine, National Yang-Ming University, Taipei 112, Taiwan, Republic of China.
authors.forename: Wei-Shu
authors.initials: WS
authors.lastname: Wang
authors.forename: Po-Min
authors.initials: PM
authors.lastname: Chen
authors.forename: Hung-Liang
authors.initials: HL
authors.lastname: Hsiao
authors.forename: Sy-Yeuan
authors.initials: SY
authors.lastname: Ju
authors.forename: Yeu
authors.initials: Y
authors.lastname: Su
mesh_terms: D015820:Cadherins / Q000378:metabolism; D002277:Carcinoma / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D002455:Cell Division; D002465:Cell Movement; D003110:Colonic Neoplasms / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D003598:Cytoskeletal Proteins / Q000378:metabolism; D018450:Disease Progression; D022001:Focal Adhesions / Q000648:ultrastructure; D006801:Humans; D016271:Proto-Oncogene Proteins c-myc / Q000378:metabolism; D013947:Thymosin / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D015534:Trans-Activators / Q000378:metabolism; D014162:Transfection; D014407:Tumor Cells, Cultured; D014410:Tumor Stem Cell Assay; D051176:beta Catenin; D000099201:Thymosin beta(4)
chemical_list: D015820:Cadherins; D003598:Cytoskeletal Proteins; D016271:Proto-Oncogene Proteins c-myc; D013947:Thymosin; D015534:Trans-Activators; D051176:beta Catenin; D000099201:Thymosin beta(4); C495270:CTNNB1 protein, human